GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Novomics Co Ltd (XKRX:283100) » Definitions » Accounts Receivable

Novomics Co (XKRX:283100) Accounts Receivable : ₩0.0 Mil (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Novomics Co Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Novomics Co's accounts receivables for the quarter that ended in Dec. 2024 was ₩0.0 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Novomics Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 was 0.00.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Novomics Co's Net-Net Working Capital per share for the quarter that ended in Dec. 2024 was ₩-1,894.22.


Novomics Co Accounts Receivable Historical Data

The historical data trend for Novomics Co's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novomics Co Accounts Receivable Chart

Novomics Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable
Get a 7-Day Free Trial 80.15 56.41 63.20 36.25 -

Novomics Co Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Accounts Receivable Get a 7-Day Free Trial 80.15 56.41 63.20 36.25 -

Novomics Co Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Novomics Co Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Novomics Co's Days Sales Outstanding for the quarter that ended in Dec. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/128.55*91
=0.00

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Novomics Co's accounts receivable are only considered to be worth 75% of book value:

Novomics Co's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(508.119+0.75 * 0+0.5 * 19.267-15097.526
-0-0)/7.697
=-1,894.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Novomics Co Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Novomics Co's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Novomics Co Business Description

Traded in Other Exchanges
N/A
Address
171 Dangsan-ro, 304, 305, 306, 306-1, Yeongdeungpo-gu, Seoul, KOR
Novomics Co Ltd is a developer of a molecular diagnosis system for cancer treatment.

Novomics Co Headlines

No Headlines